Monitoring Adverse Events in Non-Blinded Trials – Clinical Trial Design and Protocol Development
Monitoring Adverse Events in Non-Blinded Trials – Clinical Trial Design and Protocol Development “Tracking Negative Occurrences in Open-Label Trials” Introduction Monitoring adverse events in non-blinded trials is crucial to ensuring the safety of participants and the integrity of the study. Unlike blinded trials, where the investigators are unaware of the treatment given to participants, non-blinded…